| human | Q5 |
| P244 | Library of Congress authority ID | n2001130086 |
| P214 | VIAF ID | 277274613 |
| P734 | family name | Tilanus | Q65947237 |
| Tilanus | Q65947237 | ||
| Tilanus | Q65947237 | ||
| P735 | given name | Hugo | Q1242555 |
| Hugo | Q1242555 | ||
| P106 | occupation | researcher | Q1650915 |
| Q37825907 | AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application? |
| Q42994516 | Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis |
| Q42472925 | Barrett's oesophageal adenocarcinoma encompasses tumour-initiating cells that do not express common cancer stem cell markers |
| Q38433145 | CDX2 expression in columnar metaplasia of the remnant esophagus in patients who underwent esophagectomy. |
| Q42996098 | Calcineurin inhibitor tacrolimus does not interfere with the suppression of hepatitis C virus infection by interferon-alpha |
| Q33906085 | Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial |
| Q27488834 | Combined antiviral activity of interferon-α and RNA interference directed against hepatitis C without affecting vector delivery and gene silencing |
| Q36052315 | Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer |
| Q33648012 | Delay in diagnostic workup and treatment of esophageal cancer. |
| Q39063375 | Detection of spontaneous tumorigenic transformation during culture expansion of human mesenchymal stromal cells. |
| Q33837562 | Disturbance of the microRNA pathway by commonly used lentiviral shRNA libraries limits the application for screening host factors involved in hepatitis C virus infection |
| Q33550390 | Early and long-term morbidity after total laryngopharyngectomy. |
| Q37088676 | Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. |
| Q34500998 | Functional Polymorphisms Associated with Disease-Free Survival in Resected Carcinoma of the Esophagus |
| Q54536992 | Genomic analysis of early adenocarcinoma of the esophagus or gastroesophageal junction: tumor progression is associated with alteration of 1q and 8p sequences. |
| Q39422321 | Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi). |
| Q34217838 | Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation |
| Q39217305 | Heterotopic vs. orthotopic liver transplantation for chronic liver disease: a case-control comparison of short-term and long-term outcomes |
| Q39913551 | Hydroxyethyl starch-based preservation solutions enhance gene therapy vector delivery under hypothermic conditions |
| Q40285775 | Identification of a 7.1-mega base pairs minimal deletion at 14q31.1-32.11 in adenocarcinomas of the gastroesophageal junction |
| Q37970920 | Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study |
| Q35617680 | Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro-esophageal junction. |
| Q39443467 | Mapping of homozygous deletions in verified esophageal adenocarcinoma cell lines and xenografts |
| Q40084373 | Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7. |
| Q37345996 | Molecular biological challenges in he treatment of esophageal adenocarcinoma |
| Q36335009 | Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples |
| Q40209090 | Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha. |
| Q33356751 | NEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer (NEOPEC-trial). |
| Q37598622 | Neoadjuvant chemoradiotherapy for esophageal cancer: a review of meta-analyses |
| Q40645806 | Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. |
| Q47404152 | Neuroendocrine in Barrett's mucosa and adenocarcinomas of the gastroesophageal junction |
| Q36921336 | New therapeutic opportunities for hepatitis C based on small RNA. |
| Q36392575 | Optimizing intensive care capacity using individual length-of-stay prediction models |
| Q57259878 | Outcome of Esophagectomy for Cancer in Elderly Patients |
| Q35880773 | Physical fitness, fatigue, and quality of life after liver transplantation |
| Q33587884 | Preoperative and early postoperative quality of life predict survival in potentially curable patients with esophageal cancer |
| Q37676997 | Preoperative risk assessment and prevention of complications in patients with esophageal cancer |
| Q37489877 | Prospects of RNAi and microRNA-based therapies for hepatitis C. |
| Q33252347 | Protoporphyrin IX fluorescence photobleaching and the response of rat Barrett's esophagus following 5-aminolevulinic acid photodynamic therapy. |
| Q39372783 | Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomy. |
| Q40250791 | Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. |
| Q41660792 | Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma |
| Q39374652 | Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial |
| Q57260039 | Surgical Mortality in Patients With Esophageal Cancer: Development and Validation of a Simple Risk Score |
| Q31154971 | The effect of nitroglycerin on microvascular perfusion and oxygenation during gastric tube reconstruction |
| Q30351850 | The molecular biology of esophageal adenocarcinoma. |
| Q33988388 | Verification and unmasking of widely used human esophageal adenocarcinoma cell lines. |
| Q35946806 | Vitamin D Receptor Polymorphisms Are Associated with Reduced Esophageal Vitamin D Receptor Expression and Reduced Esophageal Adenocarcinoma Risk. |
| Q42879167 | mTOR signaling in liver regeneration: Rapamycin combined with growth factor treatment |
Search more.